LO
Lobe Sciences Ltd.
LOBEF · OTC
$0.05 +1.93% (+$0.00)
1M -15.27%
Market Cap $17.2M
P/E Ratio -
Div. Yield -
ROE 338.76%
Bulios Fair Price
$0.05
5.3% upside
Trenutna cena
$0.048
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LOBEF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 9.11x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 74.15%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 193.51%
Asset turnover 0.00x
ROE 338.76%
Debt
69 /100
Low Debt/Equity 0.18x
Int. coverage -27.35x
Current ratio 2.38x
Stability
29 /100
Unstable Beta 0.28x
Profitable years 0
EPS volatility 40.66%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LOBEF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Frederick Dominick Sancilio
Employees
0
Headquarters
Vancouver
Prihajajoči dogodki
28 DEC.
Earnings
Upcoming earnings report